期刊文献+

利妥昔单抗成功治疗难治性免疫性血小板减少症1例 预览 被引量:2

在线阅读 免费下载
收藏 分享 导出
摘要 患者,女,61岁,因间断牙龈出血伴皮肤出血点10天于2011年1月23日入住我院。患者于入院前10天无明显诱因出现牙龈出血,量多不易自止,同时发现皮肤出血点及瘀斑,少量鼻出血,就诊于当地医院,考虑为特发性血小板减少性紫癜伴自身免疫性溶血性贫血(Evans综合征),给予甲泼尼龙琥珀酸钠80mg(第1~5天)、静脉注射人免疫球蛋白(第1天10g,第2天25g)及输注血小板悬液治疗,
出处 《临床荟萃》 CAS 2011年第20期1814-1814,共1页 Clinical Focus
  • 相关文献

参考文献5

  • 1Cines DB, Blanchette VS. Immune thrombocytopenic purpura[J]. N Engl J Med,2002,346 (13):995-1008. 被引量:1
  • 2Yang R, Han ZC. Pathogenesis and management of chronic idiopathic thrombocytopenie purpura: an update[J]. Int J Hematol,2000,71(1) :18-24. 被引量:1
  • 3McMillan R, Durette C. Long-term outcomes in adults with chronic ITP after splenectomy failure[J]. Blood,2004,104(4 ):956-960. 被引量:1
  • 4Stasi R, Pagano A, Stipa E, et al. Rituximab chimeric anti-CD20 monoclonal antibody treatment for adults with chronic idiopathic thrombocytopenic purpura[J]. Blood,2001,98 (4) :952-957. 被引量:1
  • 5孙善芳,潘怀富.小剂量美罗华治疗难治ITP的临床疗效观察[J].实用临床医药杂志,2010,14(12):105-106. 被引量:2

二级参考文献11

  • 1I InNexus Biotechnology Inc,Scottsdale,Arizona.The autophilic anti-CD20 antibody DXL625 displays enhanced potency due to lipid raft-dependent induction of apoptosis[J].Anticancer Drugs,2010,21(5):532. 被引量:1
  • 2Kjalke M,Ezban M,Monroe DM,et al.High-dose factor VIIa increases initial thrombin generation and mediates faster platelet activation in thrombocytopenia-like conditions in a cell-based model system[J].Br J Haematol,2001,114(1):114. 被引量:1
  • 3Braendstrup P,Bjerrum OW,Nielsen OJ,et al.Rituximab chimeric anti-CD20 monoclonal antibody treatment for adult refractory idiopathic thrombocytopenic purpura[J].Am J Hematol,2005,78(4):275. 被引量:1
  • 4Kiss F,Nemeth N,Sajtos E.Examination of aggregation of various red blood cell populations can be informative in comparison of splenectomy and spleen autotransplantation in animal experiments[J].Clin Hemorheol Microcirc,2010,45(2-4):273. 被引量:1
  • 5Stasi R,Pagano A,Stipa E,et a1.Rituximab chimeric anti-CD20 monoclonal antibody treatm ent for adults with chronic idiopathic thrombocytopenic purpura[J].Blood,2001,98(4):952. 被引量:1
  • 6Koulova L,Alexandrescu D,Dutcher JP,et al.Rituximab for the treatment of refractory idiopathic thrombocytopenic purpura(ITP) and thrombotic thrombocytopenic purpura(TTP):report of three cases[J].Am J Hematol,2005,78(1):49. 被引量:1
  • 7LISA B,GIULINO MD,JAMES B,et al.Treatment with rituximab in benign and malignant hematologic disorders in children[J].The Journal of Pediatrics,2007,4:399. 被引量:1
  • 8British Comm ittee for Standards in Haematology General Haem atology Task Force.Guidelines for the investigation and management of idiopathic thrombocytopenic purpura in adults,children and in pregnancy[J].Br J Haematol,2003,120(4):574. 被引量:1
  • 9Maloney KG,Liles TM,Czerwinski DK,et al.Pha'se 1 cliincal trial using ealating single-dose infusion of chimeric anti-CD20 monoclonal an tibody(IDEC-C2Bg) in patients v,4-th lL-llrl'ent B-cell lymphoma[J].Blood,1994,84:2457. 被引量:1
  • 10Czuczman MS,Gregory SA.The future of CD20 monoclonal antibody therapy in B-cell malignancies.Leuk Lymphoma[J].2010,51(6):983. 被引量:1

共引文献1

同被引文献11

引证文献2

二级引证文献1

投稿分析

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部 意见反馈